{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:35Z","timestamp":1791119975399,"version":"4.1.0"},"reference-count":246,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.neurol.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T08:24:08Z","timestamp":1210753448000},"page":"977-994","source":"Crossref","is-referenced-by-count":7,"title":["Physiopathologie de la maladie de Huntington\u00a0: \u00e9tat des connaissances"],"prefix":"10.1016","volume":"164","author":[{"given":"E.","family":"Roze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Betuing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Deyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Caboche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2008.03.006_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration","volume":"42","author":"Alarcon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/387049a0","article-title":"Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression","volume":"387","author":"Alland","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG). repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib6","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1523\/JNEUROSCI.5409-05.2006","article-title":"CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity","volume":"26","author":"Arango","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410430321","article-title":"Complex I defect in muscle from patients with Huntington's disease","volume":"43","author":"Arenas","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10048-004-0198-8","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease","volume":"6","author":"Arning","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurol.2008.03.006_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00439-007-0393-4","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner","author":"Arning","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1). mRNA expression in Huntington's disease\u2013an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","article-title":"Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study","volume":"72","author":"Augood","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2008.03.006_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1471-4159.2004.02839.x","article-title":"Tissue transglutaminase contributes to disease progression in the R6\/2 Huntington's disease mouse model via aggregate-independent mechanisms","volume":"92","author":"Bailey","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-4159.2006.04140.x","article-title":"Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders","volume":"100","author":"Battaglia","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib19","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2008.03.006_bib21","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurol.2008.03.006_bib23","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib24","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/00001756-199707070-00031","article-title":"Fast transport and retrograde movement of huntingtin and HAP 1 in axons","volume":"8","author":"Block-Galarza","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurol.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","article-title":"Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin","volume":"8","author":"Boutell","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1523\/JNEUROSCI.1711-05.2005","article-title":"Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice","volume":"25","author":"Brami-Cherrier","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","article-title":"Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates","volume":"8","author":"Brouillet","year":"1995","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2008.03.006_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib31","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.20363","article-title":"Adult-onset chorea and mitochondrial cytopathy","volume":"20","author":"Caer","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2008.03.006_bib33","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.170280697","article-title":"Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease","volume":"97","author":"Carmichael","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurol.2008.03.006_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","author":"Cha","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2008.03.006_bib40","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib42","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib43","doi-asserted-by":"crossref","unstructured":"Charvin D, Roze E, Perrin V, et al. Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis 2008;29:22\u20139.","DOI":"10.1016\/j.nbd.2007.07.028"},{"key":"10.1016\/j.neurol.2008.03.006_bib44","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib45","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib46","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s003350010195","article-title":"HIP12 is a non-proapoptotic member of a gene family including HIP1, an interacting protein with huntingtin","volume":"11","author":"Chopra","year":"2000","journal-title":"Mamm Genome"},{"key":"10.1016\/j.neurol.2008.03.006_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/81767","article-title":"Light induces chromatin modification in cells of the mammalian circadian clock","volume":"3","author":"Crosio","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib49","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1242\/jcs.00804","article-title":"Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons","volume":"116","author":"Crosio","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neurol.2008.03.006_bib52","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1096\/fj.06-6533fje","article-title":"Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin","volume":"20","author":"Cyr","year":"2006","journal-title":"Faseb J"},{"key":"10.1016\/j.neurol.2008.03.006_bib53","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.1831768100","article-title":"Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons","volume":"100","author":"Cyr","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib54","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib55","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2008.03.006_bib57","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib58","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurol.2008.03.006_bib60","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.03.006_bib61","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib62","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib63","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M304615200","article-title":"Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II","volume":"278","author":"Edwardson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib64","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","article-title":"Huntingtin-associated protein 1 (HAP1). interacts with the p150Glued subunit of dynactin","volume":"6","author":"Engelender","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1986.tb03524.x","article-title":"Neurotransmitter glutamate: its clinical importance","volume":"74","author":"Engelsen","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2008.03.006_bib66","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib68","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib69","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib70","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-3223(99)00122-5","article-title":"Functional hyperdopaminergia in dopamine transporter knock-out mice","volume":"46","author":"Gainetdinov","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurol.2008.03.006_bib72","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-0173(97)00063-5","article-title":"Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis","volume":"26","author":"Gainetdinov","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neurol.2008.03.006_bib73","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1523\/JNEUROSCI.22-06-02174.2002","article-title":"The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase\/c-Jun module","volume":"22","author":"Garcia","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib74","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mcn.2005.12.004","article-title":"Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation","volume":"31","author":"Gomez","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2310\/7010.2006.00055","article-title":"Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature","volume":"21","author":"Gonzalez-Alegre","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2008.03.006_bib81","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2008.03.006_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila","volume":"40","author":"Gunawardena","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0959-4388(95)80072-7","article-title":"Huntington's disease: CAG genetics expands neurobiology","volume":"5","author":"Gusella","year":"1995","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neurol.2008.03.006_bib84","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1523\/JNEUROSCI.18-19-07674.1998","article-title":"The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human","volume":"18","author":"Gutekunst","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib85","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.2003.017822","article-title":"Rate and correlates of weight change in Huntington's disease","volume":"75","author":"Hamilton","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2008.03.006_bib87","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib90","first-page":"117","article-title":"Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington's disease mice","volume":"26","author":"Harris","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/387043a0","article-title":"A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression","volume":"387","author":"Heinzel","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib92","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","article-title":"Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles","volume":"9","author":"Hilditch-Maguire","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib93","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2008.03.006_bib94","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib95","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2005.03348.x","article-title":"Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers","volume":"95","author":"Hoffner","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib97","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","article-title":"The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis","volume":"98","author":"Holbert","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat Cell Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib99","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1523\/JNEUROSCI.22-19-08422.2002","article-title":"Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus","volume":"22","author":"Huang","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib100","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1073\/pnas.0505801102","article-title":"Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation","volume":"102","author":"Iwata","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib101","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-2236(00)01568-X","article-title":"Neuronal cell death in Huntington's disease: a potential role for dopamine","volume":"23","author":"Jakel","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib102","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","article-title":"Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity","volume":"9","author":"Jana","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib103","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib104","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.03.006_bib105","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","article-title":"Profound neuronal plasticity in response to inactivation of the dopamine transporter","volume":"95","author":"Jones","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib106","first-page":"357","article-title":"Dopaminergic modulation of cerebral activity and cognitive functions","volume":"38","author":"Jucaite","year":"2002","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.neurol.2008.03.006_bib107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib108","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.96.13.7388","article-title":"Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei","volume":"96","author":"Karpuj","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib109","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib110","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","article-title":"Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy","volume":"20","author":"Kegel","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib111","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib113","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21550","article-title":"Myopathy as a first symptom of Huntington's disease in a Marathon runner","author":"Kosinski","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2008.03.006_bib115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib116","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","author":"Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib117","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2005.09.023","article-title":"Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum","volume":"48","author":"Kumar","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib118","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/1096-9861(20010219)430:4<485::AID-CNE1045>3.0.CO;2-6","article-title":"Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene","volume":"430","author":"Kusakabe","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib119","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/86028","article-title":"Protein kinase C modulates NMDA receptor trafficking and gating","volume":"4","author":"Lan","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410370213","article-title":"Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals","volume":"37","author":"Landwehrmeyer","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib121","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2008.03.006_bib122","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib123","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1073\/pnas.0400243101","article-title":"Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease","volume":"101","author":"Lee","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib124","doi-asserted-by":"crossref","first-page":"12107","DOI":"10.1074\/jbc.272.18.12107","article-title":"Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-d-aspartate receptors at different sites","volume":"272","author":"Leonard","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib125","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1046\/j.1471-4159.1999.02018.x","article-title":"Tissue transglutaminase is increased in Huntington's disease brain","volume":"73","author":"Lesort","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib126","doi-asserted-by":"crossref","first-page":"40545","DOI":"10.1074\/jbc.M402229200","article-title":"Regulation of histone acetylation during memory formation in the hippocampus","volume":"279","author":"Levenson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib127","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington's disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neurol.2008.03.006_bib129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858404266777","article-title":"Huntingtin and its role in neuronal degeneration","volume":"10","author":"Li","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neurol.2008.03.006_bib131","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib132","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntington's disease gene (IT15). is widely expressed in human and rat tissues","volume":"11","author":"Li","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2004.11.001","article-title":"HAP1 and intracellular trafficking","volume":"26","author":"Li","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib134","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2008.03.006_bib135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib136","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib137","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2008.03.006_bib138","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib139","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib140","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib141","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington's disease: clinical correlates of disability and progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.03.006_bib142","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib143","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/exnr.1998.6918","article-title":"6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions","volume":"154","author":"Maragos","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib144","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","article-title":"\u2018Tissue\u2019 transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease","volume":"9","author":"Mastroberardino","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neurol.2008.03.006_bib146","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib147","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1). in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib148","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1471-4159.1998.70062406.x","article-title":"Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor","volume":"70","author":"McLaughlin","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib149","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/379353a0","article-title":"A presynaptic inositol-5-phosphatase","volume":"379","author":"McPherson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib151","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1074\/jbc.M212049200","article-title":"Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway","volume":"278","author":"Merienne","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib152","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1002\/j.1460-2075.1996.tb00917.x","article-title":"N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases","volume":"15","author":"Miki","year":"1996","journal-title":"Embo J"},{"key":"10.1016\/j.neurol.2008.03.006_bib153","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib154","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2008.03.006_bib155","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/hmg\/11.21.2547","article-title":"PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains","volume":"11","author":"Modregger","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib156","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1471-4159.2001.00059.x","article-title":"Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease","volume":"76","author":"Morton","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib157","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","article-title":"Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease","volume":"56","author":"Morton","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurol.2008.03.006_bib158","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)80218-4","article-title":"Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase","volume":"89","author":"Nagy","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib159","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib161","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/08830738060210010901","article-title":"Bilateral putaminal necrosis associated with the mitochondrial DNA A8344G myoclonus epilepsy with ragged red fibers (MERRF). mutation: an infantile case","volume":"21","author":"Orcesi","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib162","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1083\/jcb.200509091","article-title":"Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease","volume":"172","author":"Pal","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib163","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib164","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","article-title":"Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals","volume":"269","author":"Panov","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00585-4","article-title":"In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease","volume":"410","author":"Panov","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neurol.2008.03.006_bib166","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib167","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mt.sj.6300141","article-title":"Neuroprotection by Hsp104 and Hsp27 in Lentiviral-based Rat Models of Huntington's Disease","volume":"15","author":"Perrin","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.neurol.2008.03.006_bib168","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.042681599","article-title":"Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques","volume":"99","author":"Perutz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib169","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/hmg\/10.12.1243","article-title":"Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration","volume":"10","author":"Petersen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1440-1789.2006.00686.x","article-title":"Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome","volume":"26","author":"Piao","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.neurol.2008.03.006_bib171","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2007.02.007","article-title":"Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity","volume":"53","author":"Putignano","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib172","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1523\/JNEUROSCI.1409-03.2004","article-title":"Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction","volume":"24","author":"Qin","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib173","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s004150050272","article-title":"Huntington's disease and other choreas","volume":"245","author":"Quinn","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib174","first-page":"593","article-title":"Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease","volume":"57","author":"Ranen","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.patbio.2003.06.004","article-title":"Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?","volume":"52","author":"Rangone","year":"2004","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.neurol.2008.03.006_bib176","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib177","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib178","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M609885200","article-title":"Loss of huntingtin function complemented by small molecules acting as re1\/nrse silencer modulators","author":"Rigamonti","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib179","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/90498","article-title":"Molecular determinants of NMDA receptor internalisation","volume":"4","author":"Roche","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.21326","article-title":"Regulation of intracellular HAP1 trafficking","author":"Rong","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurol.2008.03.006_bib182","first-page":"57","article-title":"Excitotoxicity and the NMDA receptor--still lethal after eight years","volume":"18","author":"Rothman","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib183","doi-asserted-by":"crossref","unstructured":"Roze E, Betuing S, Deyts C, et al. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. Faseb J 2008;22:1083\u201393.","DOI":"10.1096\/fj.07-9814"},{"key":"10.1016\/j.neurol.2008.03.006_bib184","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9). trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib185","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/j.1460-9568.2006.04871.x","article-title":"Huntingtin inclusions do not down-regulate specific genes in the R6\/2 Huntington's disease mouse","volume":"23","author":"Sadri-Vakili","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib186","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington's Disease Models","author":"Sadri-Vakili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib187","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn1368","article-title":"Src kinases: a hub for NMDA receptor regulation","volume":"5","author":"Salter","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib189","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small molecules enhance autophagy and reduce toxicity in Huntington's disease models","volume":"3","author":"Sarkar","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib191","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib192","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s100380050087","article-title":"Cloning, expression analysis, and chromosomal localization of HIP1R, an isolog of huntingtin interacting protein (HIP1)","volume":"43","author":"Seki","year":"1998","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib193","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib194","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib195","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0887-8994(97)00069-6","article-title":"Juvenile Huntington disease in the Netherlands","volume":"17","author":"Siesling","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib197","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1093\/hmg\/11.23.2815","article-title":"HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis","volume":"11","author":"Singaraja","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib198","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1097-2765(00)80142-2","article-title":"SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates","volume":"2","author":"Sittler","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib199","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib200","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington's disease: a new perspective","volume":"62","author":"Smith","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neurol.2008.03.006_bib201","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1460-9568.2006.04641.x","article-title":"Histone modifications in kainate-induced status epilepticus","volume":"23","author":"Sng","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib202","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0169-328X(02)00216-4","article-title":"Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease","volume":"102","author":"Spektor","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neurol.2008.03.006_bib204","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm064","article-title":"Modulation of Nucleosome Dynamics in Huntington's Disease","author":"Stack","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib205","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib206","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease","volume":"82","author":"Starling","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurol.2008.03.006_bib207","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib209","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.03.006_bib210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib211","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib212","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.153.2.283","article-title":"Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression","volume":"153","author":"Suhr","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib213","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib214","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib216","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5). triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib217","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib218","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib219","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurol.2008.03.006_bib220","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1523\/JNEUROSCI.0589-04.2004","article-title":"Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures","volume":"24","author":"Tsankova","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib221","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21540","article-title":"Clinical correlates of mitochondrial function in Huntington's disease muscle","author":"Turner","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2008.03.006_bib222","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","article-title":"Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease","volume":"14","author":"Vacher","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib223","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurol.2008.03.006_bib224","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1073\/pnas.0704482104","article-title":"Inhibitors of metabolism rescue cell death in Huntington's disease models","volume":"104","author":"Varma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib226","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","article-title":"Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins","volume":"14","author":"Venkatraman","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib227","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/hmg\/11.22.2689","article-title":"Aggregate formation inhibits proteasomal degradation of polyglutamine proteins","volume":"11","author":"Verhoef","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib228","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(00)80774-6","article-title":"Structural view of the Ran-Importin beta interaction at 2.3 A resolution","volume":"97","author":"Vetter","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib229","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2008.03.006_bib230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/hmg\/6.3.487","article-title":"HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system","volume":"6","author":"Wanker","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib231","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epigenetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib232","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.03.006_bib233","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.neurol.2008.03.006_bib234","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib235","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","article-title":"Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin","volume":"11","author":"Wyttenbach","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib236","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1471-4159.2002.01084.x","article-title":"Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease","volume":"82","author":"Yohrling","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2008.03.006_bib237","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington's disease","volume":"241","author":"Young","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib238","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib239","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2008.03.006_bib241","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurol.2008.03.006_bib242","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2008.03.006_bib243","doi-asserted-by":"crossref","first-page":"48417","DOI":"10.1074\/jbc.M104140200","article-title":"Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation","volume":"276","author":"Zhou","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurol.2008.03.006_bib244","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.03.006_bib245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.03.006_bib246","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/2.12.2063","article-title":"Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene","volume":"2","author":"Zuhlke","year":"1993","journal-title":"Hum Mol Genet"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:59:31Z","timestamp":1738223971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378708002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":246,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0035378708002920"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2008.03.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}